BIOMAT Database Logo BIOMAT Database Logo

A studyof the pharmacokinetics of clidamycin in normal subjects and patients with chronic renal failure. 1974

J B Eastwood, and P E Gower

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002981 Clindamycin An antibacterial agent that is a semisynthetic analog of LINCOMYCIN. 7-Chloro-7-deoxylincomycin,Chlolincocin,Chlorlincocin,Cleocin,Clindamycin Hydrochloride,Clindamycin Monohydrochloride,Clindamycin Monohydrochloride, Monohydrate,Dalacin C,7 Chloro 7 deoxylincomycin,Hydrochloride, Clindamycin,Monohydrate Clindamycin Monohydrochloride,Monohydrochloride, Clindamycin,Monohydrochloride, Monohydrate Clindamycin
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections

Related Publications

J B Eastwood, and P E Gower
Pharmacokinetics of cefaclor in normal subjects and patients with chronic renal failure.
December 1977, Antimicrobial agents and chemotherapy,
J B Eastwood, and P E Gower
Pharmacokinetics of dibekacin in normal subjects and in patients with renal failure.
January 1980, The Journal of antimicrobial chemotherapy,
J B Eastwood, and P E Gower
[Pharmacokinetics of amikacin in subjects with normal renal function, in chronic renal failure and during hemodialysis].
October 1979, La Nouvelle presse medicale,
J B Eastwood, and P E Gower
Piperacillin pharmacokinetics in subjects with chronic renal failure.
March 1981, Antimicrobial agents and chemotherapy,
J B Eastwood, and P E Gower
Pharmacokinetics of nitrendipine in patients with renal failure: comparison to normal subjects.
January 1984, Journal of cardiovascular pharmacology,
J B Eastwood, and P E Gower
Pharmacokinetics of trimethoprim and sulfamethoxazole in normal subjects and in patients with renal failure.
November 1973, The Journal of infectious diseases,
J B Eastwood, and P E Gower
Pharmacokinetics of metolazone in normal subjects and in patients with cardiac or renal failure.
August 1974, Clinical pharmacology and therapeutics,
J B Eastwood, and P E Gower
[Pharmacokinetics of glaphenine in subjects with normal renal function and in patients with chronic renal insufficiency].
January 1976, Therapie,
J B Eastwood, and P E Gower
Pharmacokinetics and effect on blood pressure of doxazosin in normal subjects and patients with renal failure.
November 1986, Clinical pharmacology and therapeutics,
J B Eastwood, and P E Gower
Protein binding of aluminium in normal subjects and in patients with chronic renal failure.
January 1985, Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress,
Copied contents to your clipboard!